LOG IN

NewLink Genetics Corporation

Versiunea din 2 octombrie 2024 10:23, autor: 127.0.0.1 (discuție) (The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
(dif) ← Versiunea anterioară | Versiunea curentă (dif) | Versiunea următoare → (dif)

Pagina dedicata companiei NewLink Genetics Corporation listata cu simbolul US.NLNK

Descriere companieModificare

Lumos Pharma Inc (www.newlinkgenetics.com) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, is in late-stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD).

Grafic actiuni companieModificare

Ultimele stiri despre NewLink Genetics Corporation (US.NLNK)Modificare

Adus de la „https://wiki.tradeville.ro/index.php?title=NewLink_Genetics_Corporation&oldid=448813”